| authorizations: |
registration not required
|
| accessURL: |
http://www.iedb.org/reference/935 |
| landingPage: |
http://www.iedb.org/assay/10853 |
| type: |
Literature
|
| publicationVenue: |
FEMS Immunol Med Microbiol
|
| dates: |
2000
|
| study type: | b cell assays |
| subject species: | Pseudomonas aeruginosa Immunotype 4 |
| fullName: |
H E Gilleland
L B Gilleland
J Staczek
R N Harty
A Garcí
a-Sastre
P Palese
F R Brennan
W D Hamilton
M Bendahmane
R N Beachy
|
| method: |
ELISA
|
| name: |
Chimeric animal and plant viruses expressing epitopes of outer membrane protein F as a combined vaccine against Pseudomonas aeruginosa lung infection.
|
| description: |
Peptide shown to provide protection to source species challenge in a mouse model of chronic pulmonary infection. No increase in protective efficacy was seen for the combined administration of another epitope (peptide 9) from source species. Swiss-Prot entry corresponds to the precursor protein while the positions given in the manuscript correspond to the mature form. This protein is antigenically conserved in all strains of source species.
Pooled serum from 5 mice immunized with recombinant influenza virus expressing epitope inserted in hemagglutinin protein are shown to have antibodies directed against the epitope and the source species, but not to source species mutant lacking F protein. In mice infected with a mixture of this virus and a recombinant tobacco mosaic virus (TMV) expressing peptide 9 from the source protein, results are similar but higher titers are obtained. No reactivity is seen with the wild type carrier virus.
|
| name: |
iedb
|
| homePage: |
http://www.iedb.org |